{"database": "lobbying", "table": "lobbying_activities", "rows": [[2814393, "4509a551-f1a5-419c-adbd-bedd8d03548f", "Q2", "INLET STRATEGIES", 401106604, "COHERUS BIOSCIENCES, INC", 2022, "second_quarter", "MMM", "S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform", "Office of Management & Budget (OMB),SENATE", 37500, null, 0, 0, "2022-07-05T13:03:25-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2814393"], "units": {}, "query_ms": 80.57953300885856, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}